Modest Trim From Fairholme: Joe Is Still Worth a Look
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesFairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
Celebrity weddings captivate us, but budgeting for a destination celebration matters for everyone. This piece dives i...
As of 2026, the municipal bond market remains a steady source of funding for public projects and a tax-efficient inco...
Microsoft has slipped about 30% from its peak, sparking debate about whether now is the moment to buy. This guide bre...
Gen Z faces an AI-driven job market that keeps reshaping roles. This piece outlines adaptable skills and practical st...
A real estate investor faces federal charges after authorities allege title policies were manipulated to secure an al...
Christopher Nolan delivers a blockbuster opening for The Odyssey, outperforming Oppenheimer and marking his best star...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
CrowdStrike has shown momentum, but the stock carries risk. Here’s why I’m skeptical and how investors can approach c...
Ready to dip a modest $100 into crypto? This guide breaks down two strong bets—Solana and Cardano—and shows how to ev...
Bitcoin hovers around 82,000 as traders assess whether the bear market bottom when will be confirmed. A sustained ETF...